mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia.

Human Brain Mapping
Cláudia Régio BrambillaIrene Neuner

Abstract

Consistent findings postulate disturbed glutamatergic function (more specifically a hypofunction of the ionotropic NMDA receptors) as an important pathophysiologic mechanism in schizophrenia. However, the role of the metabotropic glutamatergic receptors type 5 (mGluR5) in this disease remains unclear. In this study, we investigated their significance (using [11 C]ABP688) for psychopathology and cognition in male patients with chronic schizophrenia and healthy controls. In the patient group, lower mGluR5 binding potential (BPND ) values in the left temporal cortex and caudate were associated with higher general symptom levels (negative and depressive symptoms), lower levels of global functioning and worse cognitive performance. At the same time, in both groups, mGluR5 BPND were significantly lower in smokers (F[27,1] = 15.500; p = .001), but without significant differences between the groups. Our findings provide support for the concept that the impaired function of mGluR5 underlies the symptoms of schizophrenia. They further supply a new perspective on the complex relationship between tobacco addiction and schizophrenia by identifying glutamatergic neurotransmission-in particularly mGluR5-as a possible connection to a shared vu...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jul 1, 1982·Archives of General Psychiatry·N C Andreasen
Feb 1, 1997·Archives of General Psychiatry·J M GoldD R Weinberger
Feb 1, 1997·Community Mental Health Journal·H L Piersma, J L Boes
Oct 1, 1998·Pharmacopsychiatry·W M Abi-SaabJ H Krystal
Dec 8, 1998·Brain and Cognition·D B BerchE M Huha
Aug 2, 2002·Archives of General Psychiatry·Dean F SalisburyRobert W McCarley
Sep 7, 2002·Applied Neuropsychology·Kathleen Bechtold KortteWhitney K Windham
Mar 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Gene G KinneyP Jeffrey Conn
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Dec 31, 2003·Nuclear Medicine and Biology·Rikki N Waterhouse
Mar 10, 2004·British Journal of Psychology·André VandierendonckArnaud Szmalec
Mar 11, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Houman HomayounBita Moghaddam
Apr 22, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Vincenzo De LucaJames L Kennedy
Mar 4, 2005·Journal of Clinical and Experimental Neuropsychology·P W Wilhelm
Sep 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Karin SchwartzMoshe Rehavi
Jun 19, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Valerie TreyerAlfred Buck
Jan 19, 2008·The British Journal of Psychiatry. Supplement·José Manuel Rodríguez-SánchezUNKNOWN PAFIP Group Study
Jan 4, 2008·The American Journal of Psychiatry·Keith H NuechterleinStephen R Marder
Jan 12, 2008·The Journal of Physiology·Dimitri M Kullmann, Karri Lamsa
Mar 4, 2008·Psychopharmacology·Ming-Huan ChanHwei-Hsien Chen
Dec 9, 2008·Trends in Pharmacological Sciences·P Jeffrey ConnCarrie K Jones
Feb 18, 2009·The Australian and New Zealand Journal of Psychiatry·Simon ChapmanKevin McGeechan
May 1, 2009·Journal of the International Neuropsychological Society : JINS·I Sánchez-CubilloF Barceló
Aug 25, 2009·Lancet·Jim van Os, Shitij Kapur
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Colleen M Niswender, P Jeffrey Conn
Apr 20, 2010·Journal of the American Geriatrics Society·Rosamaria VazzanaLuigi Ferrucci
May 13, 2010·Annals of General Psychiatry·I H Monrad Aas
Sep 28, 2010·Nuclear Medicine and Biology·Cyrill BurgerAlfred Buck

❮ Previous
Next ❯

Citations

Jul 3, 2021·Cells·Miguel A Gonzalez-LozanoKa Wan Li

❮ Previous
Next ❯

Methods Mentioned

BETA
SANS

Software Mentioned

MATRICS
Statistical Package
PMOD
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.